CCR2 is required for CD8-induced graft-versus-host disease.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Blood

• Publication date

  2005-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD-2005-05-1860PMID 16037386PMCID PMC1895329
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Graft-Versus-Host Disease

  2016cited by this paper
• Graft-versus-host disease

  2007cited by this paper
• 2-Mercaptoimidazoles, a new class of potent CCR2 antagonists.

  2005cited by this paper
• Review Articles (434 articles)

  2005cited by this paper
• CCR6 regulates CD4+ T-cell-mediated acute graft-versus-host disease responses.

  2005cited by this paper
• Increased gene expression of chemokine receptors is correlated with acute graft-versus-host disease after allogeneic stem cell transplantation.

  2005cited by this paper
• Kinetics of gene expression in murine cutaneous graft-versus-host disease.

  2004cited by this paper
• Dual Role of CCR2 during Initiation and Progression of Collagen-Induced Arthritis: Evidence for Regulatory Activity of CCR2+ T Cells1

  2004cited by this paper
• Differential expression of chemokines and chemokine receptors in murine islet allografts: the role of CCR2 and CCR5 signaling pathways.

  2004cited by this paper
• CCR2-Dependent Trafficking of F4/80dim Macrophages and CD11cdim/intermediate Dendritic Cells Is Crucial for T Cell Recruitment to Lungs Infected with Mycobacterium tuberculosis1

  2004cited by this paper
• Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells.

  2004cited by this paper
• LPAM (α4β7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease

  2004cited by this paper
• A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging

  2004cited by this paper
• A critical role for CCR2/MCP-1 interactions in the development of idiopathic pneumonia syndrome after allogeneic bone marrow transplantation.

  2004cited by this paper
• LPAM (alpha 4 beta 7 integrin) is an important homing integrin on alloreactive T cells in the development of intestinal graft-versus-host disease.

  2004cited by this paper
• FTY720-Enhanced T Cell Homing Is Dependent on CCR2, CCR5, CCR7, and CXCR4: Evidence for Distinct Chemokine Compartments1

  2004cited by this paper
• Effect of FK506 on donor T-cell functions that are responsible for graft-versus-host disease and graft-versus-leukemia effect

  2004cited by this paper
• Cancer and the chemokine network

  2004cited by this paper
• Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction

  2003cited by this paper
• Chemokine Receptor 2 (CCR2) in Atherosclerosis, Infectious Diseases, and Regulation of T‐Cell Polarization

  2003cited by this paper
• IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation.

  2003cited by this paper
• Role of CXCR3-induced donor T-cell migration in acute GVHD.

  2003cited by this paper
• Transplantation POST-BMT LUNG INJURY OCCURS INDEPENDENTLY OF THE EXPRESSION OF CCL 2 OR ITS RECEPTOR , CCR 2 , ON HOST CELLS

  2003cited by this paper
• Graft-versus-host disease can be separated from graft-versus-lymphoma effects by control of lymphocyte trafficking with FTY720.

  2003cited by this paper
• The current status of hematopoietic cell transplantation.

  2003cited by this paper
• Early changes in gene expression profiles of hepatic GVHD uncovered by oligonucleotide microarrays.

  2003cited by this paper
• CC Chemokine Receptor 2 Expression in Donor Cells Serves an Essential Role in Graft-versus-Host-Disease 1

  2003cited by this paper
• T cell infiltration and chemokine expression: relevance to the disease localization in murine graft-versus-host disease

  2002cited by this paper
• Articles on similar topics can be found in the following Blood collections

  2002cited by this paper
• Cytolytic pathways in haematopoietic stem-cell transplantation

  2002cited by this paper
• Chemokines: directing leukocyte infiltration into allografts.

  2002cited by this paper
• Chemokine receptors: multifaceted therapeutic targets

  2002cited by this paper
• Ccr2 regulates the level of MCP-1/CCL2 in vitro and at inflammatory sites and controls T cell activation in response to alloantigen.

  2002cited by this paper
• Differential Roles of CC Chemokine Ligand 2/Monocyte Chemotactic Protein-1 and CCR2 in the Development of T1 Immunity1

  2002cited by this paper
• Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis

  2001cited by this paper
• Two-sample tests for growth curves under dependent right censoring

  2001cited by this paper
• Protection from Pulmonary Fibrosis in the Absence of CCR2 Signaling1

  2001cited by this paper
• Haematopoietic cell transplantation as immunotherapy

  2001cited by this paper
• Chemokines as regulators of T cell differentiation

  2001cited by this paper
• Expression and Characterization of the Chemokine Receptors CCR2 and CCR5 in Mice1

  2001cited by this paper
• Critical role for the chemokine MCP-1/CCR2 in the pathogenesis of bronchiolitis obliterans syndrome.

  2001cited by this paper
• Chemokines and disease

  2001cited by this paper
• The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation.

  2001cited by this paper
• Lack of CCR2 Results in Increased Mortality and Impaired Leukocyte Activation and Trafficking Following Infection of the Central Nervous System with a Neurotropic Coronavirus1

  2001cited by this paper
• Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect.

  2001cited by this paper
• Cc Chemokine Receptor (Ccr)2 Is Required for Langerhans Cell Migration and Localization of T Helper Cell Type 1 (Th1)-Inducing Dendritic Cells

  2000cited by this paper
• Resistance to Experimental Autoimmune Encephalomyelitis in Mice Lacking the Cc Chemokine Receptor (Ccr2)

  2000cited by this paper
• A Mechanism for the Impaired IFN-γ Production in C-C Chemokine Receptor 2 (CCR2) Knockout Mice: Role of CCR2 in Linking the Innate and Adaptive Immune Responses1

  2000cited by this paper
• Thymic atrophy in murine acute graft-versus-host disease is effected by impaired cell cycle progression of host pro-T and pre-T cells.

  2000cited by this paper
• T-cell function and migration. Two sides of the same coin.

  2000cited by this paper
• Mice with a Selective Deletion of the CC Chemokine Receptors 5 or 2 Are Protected from Dextran Sodium Sulfate-Mediated Colitis: Lack of CC Chemokine Receptor 5 Expression Results in a NK1.1+ Lymphocyte-Associated Th2-Type Immune Response in the Intestine1

  2000cited by this paper
• Cc Chemokine Receptor 2 Is Critical for Induction of Experimental Autoimmune Encephalomyelitis

  2000cited by this paper
• Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease.

  1999cited by this paper
• CCR2: from cloning to the creation of knockout mice.

  1999cited by this paper
• Migration Kinetics and Final Destination of  Type 1 and Type 2 CD8 Effector Cells Predict Protection against Pulmonary Virus Infection

  1999cited by this paper
• IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.

  1999cited by this paper
• Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis

  1998cited by this paper
• Differential Expression of Chemokine Receptors and Chemotactic Responsiveness of Type 1 T Helper Cells (Th1s) and Th2s

  1998cited by this paper
• Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines.

  1997cited by this paper
• Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice.

  1997cited by this paper
• Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2.

  1997cited by this paper
• An Antagonist of Monocyte Chemoattractant Protein 1 (MCP-1) Inhibits Arthritis in the MRL-lpr Mouse Model

  1997cited by this paper
• Defects in Macrophage Recruitment and Host Defense in Mice Lacking the CCR2 Chemokine Receptor

  1997cited by this paper
• The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice

  1996cited by this paper
• Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease.

  1996cited by this paper
• An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin.

  1996cited by this paper
• Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant.

  1994cited by this paper
• Interleukin-3 and p210 BCR/ABL activate both unique and overlapping pathways of signal transduction in a factor-dependent myeloid cell line.

  1993cited by this paper
• Graft-versus-host disease.

  1991cited by this paper
• Cutaneous acute graft-versus-host disease to minor histocompatibility antigens in a murine model: histologic analysis and correlation to clinical disease.

  1986cited by this paper
• The antimetastatic function of concomitant antitumor immunity. II. Evidence that the generation of Ly-1+2+ effector T cells temporarily causes the destruction of already disseminated tumor cells.

  1986cited by this paper

• Macrophages in graft-versus-host disease (GVHD): dual roles as therapeutic tools and targets

  2025cites this paper
• Defining molecular circuits of CD8+ T cell responses in tissues during latent viral infection.

  2025cites this paper
• Targeting the chemokines in acute graft-versus-host disease

  2025cites this paper
• Characterizing spatial functional microniches with SpaceTravLR

  2025cites this paper
• Control of antigen-independent T-cell migration after HSCT

  2025cites this paper
• Organ-specific microenvironments drive divergent T cell evolution in acute graft-versus-host disease.

  2025cites this paper
• Pathophysiology and preclinical relevance of experimental graft-versus-host disease in humanized mice

  2024cites this paper
• Chemokine receptors are required for effector T-cell trafficking to GVHD tissues but not to bone marrow

  2024cites this paper
• Role of chemokine receptors in transplant rejection and graft-versus-host disease.

  2024cites this paper
• Association of T-Cell Phenotypes With Peri-Coronary Inflammation in People With and Without HIV and Without Cardiovascular Disease

  2024cites this paper
• Engineering donor lymphocytes with Fas ligand protein effectively prevents acute graft-versus-host disease

  2023cites this paper
• Bioconjugated Liquid-Like Solid Enhances Characterization of Solid Tumor - Chimeric Antigen Receptor T Cell Interactions.

  2023cites this paper
• Anandamide reduces the migration of lymphocytes to the intestine BY CB2 activation and reduces TNF-α in the target organs, protecting mice from graft-versus-host disease.

  2023cites this paper
• AMPK Drives Both Glycolytic and Oxidative Metabolism in T Cells During Graft-versus-host Disease

  2023cites this paper
• Donor plasmacytoid dendritic cells limit graft-versus-host disease through vasoactive intestinal polypeptide expression

  2022cites this paper
• Natural killer cells 56bright16− have higher counts in the umbilical cord blood than in the adult peripheral blood

  2022cites this paper
• Ruxolitinib Inhibits IFNγ Licensing of Human Bone Marrow Derived Mesenchymal Stromal Cells.

  2021cites this paper
• CD56brightCD16- NATURAL KILLER CELLS ARE IN HIGHER COUNTS IN THE UMBILICAL CORD BLOOD THAN IN THE PERIPHERAL BLOOD

  2021cites this paper
• CCL2-CCR2 signaling in the skin drives surfactant-induced irritant contact dermatitis via IL-1β-mediated neutrophil accumulation.

  2021cites this paper
• Mesenchymal Stem Cells Enhance Chemotaxis of Activated T Cells through the CCL2-CCR2 Axis In Vitro

  2021influential citation
• The multifaceted roles of the chemokines CCL2 and CXCL12 in osteophilic metastatic cancers

  2021cites this paper
• Targeting Interleukin-2-Inducible T-Cell Kinase (ITK) Differentiates GVL and GVHD in Allo-HSCT

  2020cites this paper
• Inhibition of ITK differentiates GVT and GVHD in allo-HSCT

  2020cites this paper
• Mast Cells Localize in Hypoxic Zones of Tumors and Secrete CCL-2 under Hypoxia through Activation of L-Type Calcium Channels

  2020cites this paper
• Treatment with Apocynin Limits the Development of Acute Graft-versus-Host Disease in Mice

  2019cites this paper
• Induction of acute graft vs. host disease in lymphopenic mice.

  2019cites this paper
• Extended CCR5 Blockade for Graft-versus-Host Disease Prophylaxis Improves Outcomes of Reduced-Intensity Unrelated Donor Hematopoietic Cell Transplantation: A Phase II Clinical Trial.

  2019cites this paper
• The Biological and Clinical Relevance of G Protein-Coupled Receptors to the Outcomes of Hematopoietic Stem Cell Transplantation: A Systematized Review

  2019cites this paper
• Nrf2 regulates CD4+ T cell-induced acute graft-versus-host disease in mice.

  2018cites this paper
• Inhibition of 5-lipoxygenase alleviates graft-versus-host disease

  2017cites this paper
• The Role of Janus Kinase Signaling in Graft-Versus-Host Disease and Graft Versus Leukemia.

  2017cites this paper
• Alterations of CCR5 and CCR7 expression on donor peripheral blood T cell subsets after mobilization with rhG-CSF correlate with acute graft-versus-host disease.

  2017cites this paper
• Dynamics of M1 macrophages in oral mucosal lesions during the development of acute graft‐versus‐host disease in rats

  2017cites this paper
• Silencing CCR2 in Macrophages Alleviates Adipose Tissue Inflammation and the Associated Metabolic Syndrome in Dietary Obese Mice

  2016cites this paper
• Recombinant IL‐7/HGFβ hybrid cytokine separates acute graft‐versus‐host‐disease from graft‐versus‐tumour activity by altering donor T cell trafficking

  2016cites this paper
• Characterization of a c-Rel Inhibitor That Mediates Anticancer Properties in Hematologic Malignancies by Blocking NF-κB-Controlled Oxidative Stress Responses.

  2016cites this paper
• Pharmacologic Inhibition of JAK1/JAK2 Signaling Reduces Experimental Murine Acute GVHD While Preserving GVT Effects

  2015cites this paper
• Nanocomposite Treatment Reduces Disease and Lethality in a Murine Model of Acute Graft-versus-Host Disease and Preserves Anti-Tumor Effects

  2015cites this paper
• Allogeneic Splenocyte Transfer and Lipopolysaccharide Inhalations Induce Differential T Cell Expansion and Lung Injury: A Novel Model of Pulmonary Graft-versus-Host Disease

  2014cites this paper
• Therapeutic benefit of bortezomib on acute GVHD is tissue specific and is associated with IL-6 levels Blood Marrow

  2014cites this paper
• ADVANCES IN HEMATOPOIETIC CELL TRANSPLANTATION Acute graft-versus-host disease: a bench-to-bedside update

  2014cites this paper
• Role of C-C motif ligand 2 and C-C motif receptor 2 in murine pulmonary graft-versus-host disease after lipopolysaccharide inhalations.

  2014cites this paper
• Acute graft-versus-host disease: a bench-to-bedside update.

  2014cites this paper
• The emerging role of soluble HLA-G in the control of chemotaxis.

  2014cites this paper
• Implication de l'axe CX3CL1/CX3CR1 dans la physiopathologie de la réaction aiguë du greffon contre l'hôte en allogreffe de cellules souches hématopoïétiques

  2014cites this paper
• Therapeutic benefit of bortezomib on acute graft-versus-host disease is tissue specific and is associated with interleukin-6 levels.

  2014cites this paper
• Homing characteristics of donor T cells after experimental allogeneic bone marrow transplantation and posttransplantation therapy for multiple myeloma.

  2013cites this paper
• Lithothamnion muelleri Controls Inflammatory Responses, Target Organ Injury and Lethality Associated with Graft-versus-Host Disease in Mice

  2013cites this paper
• Pharmacologic inhibition of PKCα and PKCθ prevents GVHD while preserving GVL activity in mice.

  2013cites this paper
• PLZF confers effector functions to donor T cells that preserve graft-versus-tumor effects while attenuating GVHD.

  2013cites this paper
• New ways to separate Graft‐versus‐Host Disease and Graft‐versus‐Tumour effects after allogeneic haematopoietic stem cell transplantation

  2013cites this paper
• immunoglobulin production via STAT3 inactivation and PAX5 induction derived CCL2 suppresses plasma cell - Mesenchymal stromal cell

  2013cites this paper
• Characterisation of leukocytes in reproductive tissues before and after pregnancy

  2013cites this paper
• Repairing Damaged Goods: Mesenchymal Stromal Cell Therapy for Secondary Failure of Hematopoiesis Post-Allogeneic Hematopoietic Cell Transplant

  2012cites this paper
• Shift of Graft-Versus-Host-Disease Target Organ Tropism by Dietary Vitamin A

  2012cites this paper
• Redirecting Gene-Modified T Cells toward Various Cancer Types Using Tagged Antibodies

  2012cites this paper
• Advances in graft-versus-host disease biology and therapy

  2012cites this paper
• Cancer Therapy : Preclinical Redirecting Gene-Modi fi ed T Cells toward Various Cancer Types Using Tagged Antibodies

  2012cites this paper
• Monocyte chemoattractant protein-1 blockade inhibits lung cancer tumor growth by altering macrophage phenotype and activating CD8+ cells.

  2011cites this paper
• The Role of Chemokines in Mediating Graft Versus Host Disease: Opportunities for Novel Therapeutics

  2011cites this paper
• PI3Kγ controls leukocyte recruitment, tissue injury, and lethality in a model of graft‐versus‐host disease in mice

  2011cites this paper
• Steroid treatment alters adhesion molecule and chemokine expression in experimental acute graft-vs.-host disease of the intestinal tract.

  2011cites this paper
• Absence of P-Selectin in Recipients of Allogeneic Bone Marrow Transplantation Ameliorates Experimental Graft-versus-Host Disease

  2010cites this paper
• DiseaseAmeliorates Experimental Graft-versus-Host Allogeneic Bone Marrow Transplantation Absence of P-Selectin in Recipients of

  2010cites this paper
• CCR2 Regulates Monocyte Recruitment As Well As CD4+ Th1 Allorecognition After Lung Transplantation

  2010cites this paper
• Donor and recipient chemokine receptor CCR5 genotype is associated with survival after bone marrow transplantation.

  2010cites this paper
• Neutralizing Antibody Administration of Anti-CXCR3 Graft-versus-Host Disease by In Vivo Alloreactive T Cell-Mediated A New Approach to the Blocking of

  2010cites this paper
• PKCθ Is Required For Alloreactivity And GVHD But Not For Immune Responses Toward Leukemia And Infection In Mice

  2010cites this paper
• Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth.

  2010cites this paper
• CCL2 blockade augments cancer immunotherapy.

  2010cites this paper
• NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor/Leukemia Reaction.

  2010cites this paper
• Проявление иммунокорригирующего эффекта криоконсервированных клеток фетальной печени разных сроков гестации в условиях развития экспериментальной модели реакции «Трансплантат против хозяина»*

  2010influential citation
• In vivo two-photon imaging reveals monocyte-dependent neutrophil extravasation during pulmonary inflammation

  2010cites this paper
• Endotheliale Progenitorzellen und Natürliche Killerzellen bei Allogener Stammzelltransplantation und Tumor-Immuntherapie

  2010cites this paper
• The chemokine system: a possible therapeutic target in acute graft versus host disease.

  2010cites this paper
• The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease.

  2010cites this paper
• NOD2 regulates hematopoietic cell function during graft-versus-host disease

  2009cites this paper
• Chemokine and chemokine receptor expression analysis in target organs of acute graft-versus-host disease

  2009cites this paper
• PKCtheta is required for alloreactivity and GVHD but not for immune responses toward leukemia and infection in mice.

  2009cites this paper
• Selective Inhibition of CCR2 Expressing Lymphomyeloid Cells in Experimental Autoimmune Encephalomyelitis by a GM-CSF-MCP1 Fusokine1

  2009influential citation
• Anti-CD3 preconditioning separates GVL from GVHD via modulating host dendritic cell and donor T-cell migration in recipients conditioned with TBI.

  2009cites this paper
• Graft-versus-Leukemia Effect of Nonmyeloablative Stem Cell Transplantation

  2009cites this paper
• Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation.

  2009cites this paper
• Recombinant human granulocyte colony-stimulating factor significantly decreases the expression of CXCR3 and CCR6 on T cells and preferentially induces T helper cells to a T helper 17 phenotype in peripheral blood harvests.

  2009cites this paper
• Impaired Effector Memory T-Cell Regulation Facilitates Graft Versus Host Disease in CCR7-Deficient Bone Marrow Transplant Chimeras

  2009cites this paper
• Upregulation of plasma CCL8 in mouse model of graft-vs-host disease.

  2009cites this paper
• Immunomodulation and pharmacological strategies in the treatment of graft-versus-host disease

  2008cites this paper
• CCR2 Mediates Homeostatic and Inflammatory Release of Gr1high Monocytes from the Bone Marrow, but Is Dispensable for Bladder Infiltration in Bacterial Urinary Tract Infection1

  2008cites this paper
• CCL 8 is a potential molecular candidate for the diagnosis of graft-versus-host disease

  2008cites this paper
• A New Approach to the Blocking of Alloreactive T Cell-Mediated Graft-versus-Host Disease by In Vivo Administration of Anti-CXCR3 Neutralizing Antibody1

  2008cites this paper
• Off‐the‐shelf tumor immunotherapy with genetically enhanced allogeneic T cell precursors

  2008cites this paper
• graft-versus-host disease CCL8 is a potential molecular candidate for the diagnosis of

  2008cites this paper
• Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction.

  2008cites this paper
• Efficacy of a Nanocochleate-Encapsulated 3,5-Diaryl-s-Triazole Derivative in a Murine Model of Graft-Versus-Host Disease

  2008cites this paper
• Mesenchymal stromal cell – derived CCL 2 suppresses plasma cell immunoglobulin production via STAT 3 inactivation and PAX 5 induction

  2008cites this paper
• CCL8 is a potential molecular candidate for the diagnosis of graft-versus-host disease.

  2008cites this paper
• Polymorphisms of cytokine and innate immunity genes and GVHD.

  2008cites this paper
• Tract Infection for Bladder Infiltration in Bacterial Urinary from the Bone Marrow, but Is Dispensable Monocytes high Inflammatory Release of Gr1 CCR2 Mediates Homeostatic and

  2008cites this paper
• Antibody Administration of Anti-CXCR 3 Neutralizing Graft-versus-Host Disease by In Vivo Alloreactive

  2008cites this paper
• Organ-derived dendritic cells have differential effects on alloreactive T cells.

  2008cites this paper